Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Top Cited Papers
- 7 October 2014
- journal article
- review article
- Published by Wiley in Angewandte Chemie
- Vol. 53 (46), 12320-12364
- https://doi.org/10.1002/anie.201403036
Abstract
In medicine, nanotechnology has sparked a rapidly growing interest as it promises to solve a number of issues associated with conventional therapeutic agents, including their poor water solubility (at least, for most anticancer drugs), lack of targeting capability, nonspecific distribution, systemic toxicity, and low therapeutic index. Over the past several decades, remarkable progress has been made in the development and application of engineered nanoparticles to treat cancer more effectively. For example, therapeutic agents have been integrated with nanoparticles engineered with optimal sizes, shapes, and surface properties to increase their solubility, prolong their circulation half‐life, improve their biodistribution, and reduce their immunogenicity. Nanoparticles and their payloads have also been favorably delivered into tumors by taking advantage of the pathophysiological conditions, such as the enhanced permeability and retention effect, and the spatial variations in the pH value. Additionally, targeting ligands (e.g., small organic molecules, peptides, antibodies, and nucleic acids) have been added to the surface of nanoparticles to specifically target cancerous cells through selective binding to the receptors overexpressed on their surface. Furthermore, it has been demonstrated that multiple types of therapeutic drugs and/or diagnostic agents (e.g., contrast agents) could be delivered through the same carrier to enable combination therapy with a potential to overcome multidrug resistance, and real‐time readout on the treatment efficacy. It is anticipated that precisely engineered nanoparticles will emerge as the next‐generation platform for cancer therapy and many other biomedical applications.Keywords
This publication has 101 references indexed in Scilit:
- DNA Self‐Assembly of Targeted Near‐Infrared‐Responsive Gold Nanoparticles for Cancer Thermo‐ChemotherapyAngewandte Chemie, 2012
- Recent advances in stealth coating of nanoparticle drug delivery systemsWIREs Nanomedicine and Nanobiotechnology, 2012
- Luminescent Gold Nanoparticles with Efficient Renal ClearanceAngewandte Chemie, 2011
- A Temperature‐Sensitive Drug Release System Based on Phase‐Change MaterialsAngewandte Chemie, 2010
- Bright Three‐Photon Luminescence from Gold/Silver Alloyed Nanostructures for Bioimaging with Negligible Photothermal ToxicityAngewandte Chemie, 2010
- Fabrication of Microbeads with a Controllable Hollow Interior and Porous Wall Using a Capillary Fluidic DeviceAdvanced Functional Materials, 2009
- Nanogels as Pharmaceutical Carriers: Finite Networks of Infinite CapabilitiesAngewandte Chemie-International Edition, 2009
- Size‐Dependent Endocytosis of NanoparticlesAdvanced Materials, 2009
- Protease‐Triggered Unveiling of Bioactive NanoparticlesSmall, 2008
- Light‐Activated Nanoimpeller‐Controlled Drug Release in Cancer CellsSmall, 2008